Log In
Print
BCIQ
Print
Print this Print this
 

PS110

  Manage Alerts
Collapse Summary General Information
Company Proteome Sciences plc
DescriptionCasein kinase 1 delta (CSNK1D; CKI-delta) inhibitor
Molecular Target Casein kinase 1 delta (CSNK1D) (CKI-delta)
Mechanism of ActionCasein kinase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today